id: NEW:gross_total_resection_pineoblastoma_to_NEW:pineoblastoma_survival
name: Gross Total Resection of Pineoblastoma â†’ Adult Pineoblastoma Survival
from_node:
  node_id: NEW:gross_total_resection_pineoblastoma
  node_name: Gross Total Resection of Pineoblastoma
to_node:
  node_id: NEW:pineoblastoma_survival
  node_name: Adult Pineoblastoma Survival
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Gross total resection (GTR) achieves complete surgical removal of the pineoblastoma
  tumor mass from the pineal region'
- 'Step 2: Complete tumor removal eliminates the primary source of malignant cells,
  reducing tumor burden and potential for local progression'
- 'Step 3: GTR provides better conditions for adjuvant therapies (radiotherapy and
  chemotherapy) by minimizing residual disease that could serve as a nidus for recurrence'
- 'Step 4: Reduced tumor burden translates to improved survival outcomes compared
  to subtotal resection or no surgery, particularly within the first five years post-diagnosis'
evidence:
  quality_rating: B
  n_studies: 32
  primary_citation: Xiufeng Chu et al. 2024. A systematic review of adult pineoblastoma.
    Frontiers in oncology.
  supporting_citations: []
description: Gross total resection of adult pineoblastoma is associated with improved
  survival compared to subtotal resection or no surgery. Kaplan-Meier analysis across
  108 cases from 32 studies demonstrated significant survival benefit (P=0.018) over
  a 10-year follow-up period. While multivariate COX analysis showed GTR tends to
  improve survival within five years (P=0.079), the combination of GTR with radiotherapy
  and chemotherapy provides the best prognostic outcomes for this rare CNS malignancy.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: Time since diagnosis
  direction: weakens
  strength: moderate
  description: GTR benefit tends to be more pronounced within five years (P=0.079
    in multivariate analysis); long-term benefit may be less distinct
- name: Adjuvant radiotherapy
  direction: strengthens
  strength: strong
  description: Radiotherapy is an independent beneficial prognostic factor (P<0.001)
    and likely synergizes with GTR for optimal survival outcomes
- name: Adjuvant chemotherapy
  direction: strengthens
  strength: moderate
  description: Chemotherapy was beneficial for survival (P=0.020) and may enhance
    GTR effectiveness
